tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LPCN Stock Latest News

Lipocine updates investor presentation and corporate materials
Company AnnouncementsLipocine updates investor presentation and corporate materials
15h ago
8K
LPCN
Lipocine Advances Phase 3 Postpartum Depression Drug Trial
PremiumCompany Announcements
Lipocine Advances Phase 3 Postpartum Depression Drug Trial
22h ago
8K
LPCN
Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned
PremiumThe Fly
Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned
23h ago
LPCN
Lipocine Advances Phase 3 Trial for PPD Treatment
PremiumCompany Announcements
Lipocine Advances Phase 3 Trial for PPD Treatment
28d ago
8K
LPCN
Lipocine ‘s PPD Phase 3 study hits 80% enrollment milestone
PremiumThe Fly
Lipocine ‘s PPD Phase 3 study hits 80% enrollment milestone
28d ago
LPCN
Lipocine Showcases LPCN 2101 at Epilepsy Meeting
PremiumCompany AnnouncementsLipocine Showcases LPCN 2101 at Epilepsy Meeting
1M ago
8K
LPCN
Lipocine Announces Positive Interim Results for PPD Trial
Premium
Company Announcements
Lipocine Announces Positive Interim Results for PPD Trial
2M ago
8K
LPCN
Lipocine Updates Corporate Presentation for Investors
Premium
Company Announcements
Lipocine Updates Corporate Presentation for Investors
2M ago
8K
LPCN
Lipocine reports ‘promising’ safety profile in Phase 3 trial of LPCN 1154
PremiumThe Fly
Lipocine reports ‘promising’ safety profile in Phase 3 trial of LPCN 1154
2M ago
LPCN
Lipocine price target lowered to $7 from $8 at H.C. Wainwright
PremiumThe Fly
Lipocine price target lowered to $7 from $8 at H.C. Wainwright
2M ago
LPCN
Lipocine Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Lipocine Inc. Reports Q3 2025 Financial Results
2M ago
LPCN
Lipocine reports Q3 EPS (59c) vs. (44c) last year
PremiumThe Fly
Lipocine reports Q3 EPS (59c) vs. (44c) last year
2M ago
LPCN
Lipocine Presents Promising LPCN 2401 Data at ObesityWeek
PremiumCompany AnnouncementsLipocine Presents Promising LPCN 2401 Data at ObesityWeek
2M ago
8K
LPCN
Lipocine Inc (LPCN) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Lipocine Inc (LPCN) Q3 Earnings Cheat Sheet
2M ago
LPCN
Lipocine Advances Phase 3 Trial for PPD Treatment
Premium
Company Announcements
Lipocine Advances Phase 3 Trial for PPD Treatment
3M ago
8K
LPCN
Lipocine provides update on Phase 3 clinical trial in postpartum depression
PremiumThe Fly
Lipocine provides update on Phase 3 clinical trial in postpartum depression
4M ago
LPCN
Lipocine Seeks Regulatory Clarity on LPCN 2401 Study
PremiumCompany Announcements
Lipocine Seeks Regulatory Clarity on LPCN 2401 Study
4M ago
8K
LPCN
Lipocine to Present at Global Investment Conference
PremiumCompany Announcements
Lipocine to Present at Global Investment Conference
4M ago
8K
LPCN
Lipocine Participates in H.C. Wainwright Investor Conference
PremiumCompany Announcements
Lipocine Participates in H.C. Wainwright Investor Conference
4M ago
8K
LPCN
Lipocine’s LPCN 2101 Accepted for AES Presentation
PremiumCompany AnnouncementsLipocine’s LPCN 2101 Accepted for AES Presentation
5M ago
8K
LPCN
Lipocine’s LPCN 1154: A Promising Breakthrough in Postpartum Depression Treatment
Premium
Ratings
Lipocine’s LPCN 1154: A Promising Breakthrough in Postpartum Depression Treatment
5M ago
LPCN
Lipocine Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
Lipocine Inc. Reports Q2 2025 Financial Results
5M ago
LPCN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >